SEARCH

SEARCH BY CITATION

  • 1
    Hoofnagle, J. H., Course and outcome of hepatitis C. Hepatology 2002. 36: S219.
  • 2
    Wasley, A. and Alter, M. J., Epidemiology of hepatitis C: geographic differences and temporal trends. Semin. Liver Dis. 2000. 20: 116.
  • 3
    Lechner, F., Wong, D. K., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G. et al., Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 2000. 191: 14991512.
  • 4
    Shoukry, N. H., Cawthon, A. G. and Walker, C. M., Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu. Rev. Microbiol. 2004. 58: 391424.
  • 5
    Cooper, S., Erickson, A. L., Adams, E. J., Kansopon, J., Weiner, A. J., Chien, D. Y., Houghton, M. et al., Analysis of a successful immune response against hepatitis C virus. Immunity 1999. 10: 439449.
  • 6
    Thimme, R., Oldach, D., Chang, K. M., Steiger, C., Ray, S. C. and Chisari, F. V., Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 2001. 194: 13951406.
  • 7
    Gruener, N. H., Lechner, F., Jung, M. C., Diepolder, H., Gerlach, T., Lauer, G., Walker, B. et al., Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J. Virol. 2001. 75: 55505558.
  • 8
    Urbani, S., Boni, C., Missale, G., Elia, G., Cavallo, C., Massari, M., Raimondo, G. and Ferrari, C., Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J. Virol. 2002. 76: 1242312434.
  • 9
    Wedemeyer, H., He, X. S., Nascimbeni, M., Davis, A. R., Greenberg, H. B., Hoofnagle, J. H., Liang, T. J. et al., Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J. Immunol. 2002. 169: 34473458.
  • 10
    Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J., Suresh, M., Altman, J. D. and Ahmed, R., Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 1998. 188: 22052213.
  • 11
    Tester, I., Smyk-Pearson, S., Wang, P., Wertheimer, A., Yao, E., Lewinsohn, D. M., Tavis, J. E. and Rosen, H. R., Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. J. Exp. Med. 2005. 201: 17251731.
  • 12
    Meyer-Olson, D., Shoukry, N. H., Brady, K. W., Kim, H., Olson, D. P., Hartman, K., Shintani, A. K. et al., Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J. Exp. Med. 2004. 200: 307319.
  • 13
    Gerlach, J. T., Diepolder, H. M., Jung, M. C., Gruener, N. H., Schraut, W. W., Zachoval, R., Hoffmann, R. et al., Recurrence of hepatitis C virus after loss of virus-specific CD4 T-cell response in acute hepatitis C. Gastroenterology 1999. 117: 933941.
  • 14
    Lucas, M., Vargas-Cuero, A. L., Lauer, G. M., Barnes, E., Willberg, C. B., Semmo, N., Walker, B. D. et al., Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells. J. Immunol. 2004. 172: 17441753.
  • 15
    Moretta, A., Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2002. 2: 957961.
  • 16
    Moretta, A., The dialogue between human natural killer cells and dendritic cells . Curr. Opin. Immunol. 2005. 17: 306311.
  • 17
    Ferlazzo, G., Semino, C. and Melioli, G., HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunol. Lett. 2001. 76: 3741.
  • 18
    Ferlazzo, G., Morandi, B., D'Agostino, A., Meazza, R., Melioli, G., Moretta, A. and Moretta, L., The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur. J. Immunol. 2003. 33: 306313.
  • 19
    Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M. and Munz, C., Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 2002. 195: 343351.
  • 20
    Vitale, M., Della Chiesa, M., Carlomagno, S., Pende, D., Arico, M., Moretta, L. and Moretta, A., NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 2005. 106: 566571.
  • 21
    Vankayalapati, R., Wizel, B., Weis, S. E., Safi, H., Lakey, D. L., Mandelboim, O., Samten, B. et al., The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 2002. 168: 34513457.
  • 22
    Vankayalapati, R., Klucar, P., Wizel, B., Weis, S. E., Samten, B., Safi, H., Shams, H. and Barnes, P., NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen J. Immunol. 2004. 172: 130137.
  • 23
    Poli, G., Introna, M., Zanaboni, F., Peri, G., Carbonari, M., Aiuti, F., Lazzarin, A. et al., Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. Clin. Exp. Immunol. 1985. 62: 128135.
  • 24
    Cai, Q., Huang, X. L., Rappocciolo, G. and Rinaldo, C. R. Jr., Natural killer cell responses in homosexual men with early HIV infection. J. Acquir. Immune Defic. Syndr. 1990. 3: 669676.
  • 25
    De Maria, A., Fogli, M., Costa, P., Murdaca, G., Puppo, F., Mavilio, D., Moretta, A. and Moretta, L., The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44 ). Eur. J. Immunol. 2003. 33: 24102415.
  • 26
    Fogli, M., Costa, P., Murdaca, G., Setti, M., Mingari, M. C., Moretta, L., Moretta, A. and De Maria, A., Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients. Eur. J. Immunol. 2004. 34: 23132321.
  • 27
    Mela, C. M., Burton, C. T., Imami, N., Nelson, M., Steel, A., Gazzard, B. G., Gotch, F. M. and Goodier, M. R., Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy. AIDS 2005. 19: 17611769.
  • 28
    Bonaparte, M. I. and Barker, E., Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes. AIDS 2003. 17: 487494.
  • 29
    Kanto, T., Inoue, M., Miyatake, H., Sato, A., Sakakibara, M., Yakushijin, T., Oki, C. et al., Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J. Infect. Dis. 2004. 190: 19191926.
  • 30
    Goutagny, N., Vieux, C., Decullier, E., Ligeoix, B., Epstein, A., Trepo, C., Couzigou, P. et al., Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection. J. Infect. Dis. 2004. 189: 16461655.
  • 31
    Dolganiuc, A., Kodys, K., Kopasz, A., Marshall, C., Do, T., Romics, L. Jr., Mandrekar, P. et al., Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J. Immunol. 2003. 170: 56155624.
  • 32
    Longman, R. S., Talal, A. H., Jacobson, I. M., Rice, C. M. and Albert, M. L., Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J. Infect. Dis. 2005. 192: 497503.
  • 33
    Crotta, S., Stilla, A., Wack, A., D'Andrea, A., Nuti, S., D'Oro, U., Mosca, M. et al., Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 2002. 195: 3541.
  • 34
    Jinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Groh, V., Spies, T., Suzuki, T. et al., Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J. Immunol. 2003. 171: 54235429.
  • 35
    Jinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Miyagi, T., Suzuki, T., Kanazawa, Y. et al., Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J. Immunol. 2004. 173: 60726081.
  • 36
    Lechmann, M., Woitas, R. P., Langhans, B., Kaiser, R., Ihlenfeldt, H. G., Jung, G., Sauerbruch, T. and Spengler, U., Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C. J. Hepatol. 1999. 31: 971978.
  • 37
    Godkin, A., Jeanguet, N., Thursz, M., Openshaw, P. and Thomas, H., Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. Eur. J. Immunol. 2001. 31: 14381446
  • 38
    Castriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R. et al., Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc. Natl. Acad. Sci. USA 2003. 100: 41204125.
  • 39
    Tsai, S. L., Liaw, Y. F., Chen, M. H., Huang, C. Y. and Kuo, G. C., Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997. 25: 449458.
  • 40
    Urbani, S., Boni, C., Missale, G., Elia, G., Cavallo, C., Massari, M., Raimondo, G. and Ferrari, C., Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J. Virol. 2002. 76: 1242312434.
  • 41
    Nattermann, J., Feldmann, G., Ahlenstiel, G., Langhans, B., Sauerbruch, T. and Spengler, U., Surface expression and cytolytic function of NK cell receptors is altered in chronic hepatitis C . Gut 2006. 55: 869877.
  • 42
    Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J. et al., HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004. 305: 872874.
  • 43
    Costello, R. T., Sivori, S., Marcenaro, E., Lafage-Pochitaloff, M., Mozziconacci, M. J., Reviron, D., Gastaut, J. A. et al., Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 2002. 99: 36613667.
  • 44
    Fauriat, C., Moretta, A., Olive, D. and Costello, R. T., Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients. Blood 2005. 106: 21862188.
  • 45
    Sivori, S., Pende, D., Bottino, C., Marcenaro, E., Pessino, A., Biassoni, R., Moretta, L. and Moretta, A., NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol. 1999. 29: 16561666.
  • 46
    Guma, M., Angulo, A., Vilches, C., Gomez-Lozano, N., Malats, N. and Lopez-Botet, M., Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004. 104: 36643671.
  • 47
    Gramenzi, A., Andreone, P., Loggi, E., Foschi, F. G., Cursaro, C., Margotti, M., Biselli, M. and Bernardi, M., Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. J. Viral. Hepat. 2005. 12: 525530.
  • 48
    Rigopoulou, E. I., Abbott, W. G., Haigh, P. and Naoumov, N. V., Blocking of interleukin-10 receptor--a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus. Clin. Immunol. 2005. 117: 5764.
  • 49
    Betts, M. R., Brenchley, J. M., Price, D. A., De Rosa, S. C., Douek, D. C., Roederer, M. and Koup, R. A., Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 2003. 281: 6578.
  • 50
    Barry, M. and Bleackley, R. C., Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol. 2002. 2: 401409.
  • 51
    Betts, M. R., Price, D. A., Brenchley, J. M., Lore, K., Guenaga, F. J., Smed-Sorensen, A., Ambrozak, D. R. et al., The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration. J. Immunol. 2004. 172: 64076417.